Atlas Trials

Recurrent Transformed Non-Hodgkin Lymphoma

11 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Recurrent Transformed Non-Hodgkin Lymphoma

RecordFirmDate
Testing the Addition of an Immunotherapy Agent, Atezolizumab, When Given With the Usual Chemo-Immunotherapy Drug Combination (Rituximab Plus Gemcitabine and Oxaliplatin) for Relapsed/Refractory (That Has Come Back or Not Responded to Treatment) Transformed Diffuse Large B-Cell Lymphoma (NCT03321643)National Cancer Institute (NCI)2018-09-18
huJCAR014 CAR-T Cells in Treating Adult Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia (NCT03103971)Fred Hutchinson Cancer Center2017-11-03
Pembrolizumab and Vorinostat in Patients With Relapsed or Refractory DLBCL, FCL or HL. (NCT03150329)City of Hope Medical Center2017-07-18
R-ICE and Lenalidomide in Treating Patients With First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (NCT02628405)Academic and Community Cancer Research United2016-05-20
Lenalidomide Therapy After Chemotherapy & Stem Cell Transplant in Treating Chemotherapy Resistan Non-Hodgkin Lymphoma (NCT01035463)University of Nebraska2009-11-12

Track Recurrent Transformed Non-Hodgkin Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.